BIBLIOS

  Sistema de Gestão de Referências Bibliográficas de Ciências

Modo Visitante (Login)
Need help?


Voltar

Detalhes Referência

Tipo
Artigos em Revista

Tipo de Documento
Artigo Completo

Título
Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view

Participantes na publicação
K. De Boeck (Author)
T. Lee (Author)
M. Amaral (Author)
Dep. Química e Bioquímica
BioISI
P. Drevinek (Author)
J.S. Elborn (Author)
I. Fajac (Author)
E. Kerem (Author)
J.C. Davies (Author)

Data de Publicação
2020-09

Suporte
Journal of Cystic Fibrosis

Identificadores da Publicação
ISSN - 1569-1993

Editora
Elsevier BV

Volume
19
Fascículo
5

Número de Páginas
7
Página Inicial
688
Página Final
695

Identificadores do Documento
DOI - https://doi.org/10.1016/j.jcf.2020.05.012
URL - http://dx.doi.org/10.1016/j.jcf.2020.05.012

Identificadores de Qualidade
Web Of Science Q1 (2019) - 4.759 - RESPIRATORY SYSTEM - SCIE
SCOPUS Q1 (2019) - 6.6 - Pediatrics, Perinatology and Child Health
SCOPUS Q1 (2019) - 6.6 - Pulmonary and Respiratory Medicine
SCIMAGO Q1 (2019) - 1.411 - Pulmonary and Respiratory Medicine
SCIMAGO Q1 (2019) - 1.411 - Pediatrics, Perinatology and Child Health
Web Of Science Q1 (2020) - 5.482 - RESPIRATORY SYSTEM - SCIE
SCIMAGO Q1 (2020) - 2.049 - Pulmonary and Respiratory Medicine
SCOPUS Q1 (2020) - 7.5 - Pulmonary and Respiratory Medicine


Exportar referência

APA
K. De Boeck, T. Lee, M. Amaral, P. Drevinek, J.S. Elborn, I. Fajac, E. Kerem, J.C. Davies, (2020). Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view. Journal of Cystic Fibrosis, 19, 688-695. ISSN 1569-1993. eISSN . http://dx.doi.org/10.1016/j.jcf.2020.05.012

IEEE
K. De Boeck, T. Lee, M. Amaral, P. Drevinek, J.S. Elborn, I. Fajac, E. Kerem, J.C. Davies, "Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view" in Journal of Cystic Fibrosis, vol. 19, pp. 688-695, 2020. 10.1016/j.jcf.2020.05.012

BIBTEX
@article{49484, author = {K. De Boeck and T. Lee and M. Amaral and P. Drevinek and J.S. Elborn and I. Fajac and E. Kerem and J.C. Davies}, title = {Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view}, journal = {Journal of Cystic Fibrosis}, year = 2020, pages = {688-695}, volume = 19 }